Scientists repurposed anti-cancer drugs based on a rare metal into promising antibacterial agents that can target life-threatening multi-drug resistant superbugs.

In 10 seconds? Researchers have made the structure of ruthenium-based anti-cancer drugs similar to that of an antimicrobial agent and found that the new compound was effective against certain antibiotic-resistant bugs.

Continue reading

Try our 7-day free trial and access the full article with citations and resources.

Try For Free Already have an account? Sign in